OACC Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

1

[ ] | [ ]

NASDAQ | Common Stock

Price
$10.11
Increased by 0.00%
Dollar volume (20D)
272.40 K
ADR%
1.05
Shares float
17.80 M
Shares short
3.78 K [0.02%]
Shares outstanding
19.78 M
Market cap
250.01 M
Beta
N/A
Price/earnings
N/A
20D range
10.05 10.85
50D range
9.96 10.85
200D range
9.95 10.85

Oaktree Acquisition Corp.

III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.

The company was incorporated in 2024 and is based in Los Angeles, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY